 | • レポートコード：MRC2102QY11727 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のプロテアーゼ阻害剤市場について種類別（試薬用、医薬品用、その他）、用途別（バイオテクノロジー、医学、微生物学、農業、医薬品、食品添加物、化粧品）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・プロテアーゼ阻害剤市場の概要 ・世界の主要地域別プロテアーゼ阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のプロテアーゼ阻害剤市場規模2015-2026：種類別（試薬用、医薬品用、その他） ・世界のプロテアーゼ阻害剤市場規模2015-2026：用途別（バイオテクノロジー、医学、微生物学、農業、医薬品、食品添加物、化粧品） ・プロテアーゼ阻害剤の米国市場規模2015-2020 ・プロテアーゼ阻害剤のヨーロッパ市場規模2015-2020 ・プロテアーゼ阻害剤の中国市場規模2015-2020 ・プロテアーゼ阻害剤の日本市場規模2015-2020 ・プロテアーゼ阻害剤の東南アジア市場規模2015-2020 ・プロテアーゼ阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・プロテアーゼ阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・プロテアーゼ阻害剤の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Protease Inhibitors Market
The global Protease Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Protease Inhibitors Scope and Market Size
The global Protease Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Protease Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Protease Inhibitors market is segmented into
Reagent grade
Pharmaceutical
Grade other
Segment by Application, the Protease Inhibitors market is segmented into
Biotechnology
Medicine
Microbiology
Agriculture
Pharmaceuticals
Food additives
Cosmetics
The Protease Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the Protease Inhibitors market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Protease Inhibitors Market Share Analysis
Protease Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Protease Inhibitors business, the date to enter into the Protease Inhibitors market, Protease Inhibitors product introduction, recent developments, etc.
The major vendors covered:
CSL Ltd. (Australia)
Grifols S.A (Spain)
Baxalta Incorporated (U.S.)
Octapharma AG (Switzerland)
Kedrion S.p.A (Italy)
China Biologic Products, Inc. (China)
Biotest AG (Germany)
LFB S.A (France)
Bio Product Laboratory Ltd. (U.K.)
Sanquin (Netherlands)
1 Protease Inhibitors Market Overview
1.1 Protease Inhibitors Product Scope
1.2 Protease Inhibitors Segment by Type
1.2.1 Global Protease Inhibitors Sales by Type (2020-2026)
1.2.2 Reagent grade
1.2.3 Pharmaceutical
1.2.4 Grade other
1.3 Protease Inhibitors Segment by Application
1.3.1 Global Protease Inhibitors Sales Comparison by Application (2020-2026)
1.3.2 Biotechnology
1.3.3 Medicine
1.3.4 Microbiology
1.3.5 Agriculture
1.3.6 Pharmaceuticals
1.3.7 Food additives
1.3.8 Cosmetics
1.4 Protease Inhibitors Market Estimates and Forecasts (2015-2026)
1.4.1 Global Protease Inhibitors Sales Growth Rate (2015-2026)
1.4.2 Global Protease Inhibitors Revenue and Growth Rate (2015-2026)
1.4.3 Global Protease Inhibitors Price Trends (2015-2026)
2 Protease Inhibitors Estimate and Forecast by Region
2.1 Global Protease Inhibitors Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Protease Inhibitors Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Protease Inhibitors Sales Market Share by Region (2015-2020)
2.2.2 Global Protease Inhibitors Revenue Market Share by Region (2015-2020)
2.3 Global Protease Inhibitors Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Protease Inhibitors Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Protease Inhibitors Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Protease Inhibitors Estimates and Projections (2015-2026)
2.4.2 Europe Protease Inhibitors Estimates and Projections (2015-2026)
2.4.3 China Protease Inhibitors Estimates and Projections (2015-2026)
2.4.4 Japan Protease Inhibitors Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Protease Inhibitors Estimates and Projections (2015-2026)
2.4.6 India Protease Inhibitors Estimates and Projections (2015-2026)
3 Global Protease Inhibitors Competition Landscape by Players
3.1 Global Top Protease Inhibitors Players by Sales (2015-2020)
3.2 Global Top Protease Inhibitors Players by Revenue (2015-2020)
3.3 Global Protease Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Protease Inhibitors as of 2019)
3.4 Global Protease Inhibitors Average Price by Company (2015-2020)
3.5 Manufacturers Protease Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Protease Inhibitors Players (Opinion Leaders)
4 Global Protease Inhibitors Market Size by Type
4.1 Global Protease Inhibitors Historic Market Review by Type (2015-2020)
4.1.1 Global Protease Inhibitors Sales Market Share by Type (2015-2020)
4.1.2 Global Protease Inhibitors Revenue Market Share by Type (2015-2020)
4.1.3 Global Protease Inhibitors Price by Type (2015-2020)
4.2 Global Protease Inhibitors Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Protease Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Protease Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Global Protease Inhibitors Price Forecast by Type (2021-2026)
5 Global Protease Inhibitors Market Size by Application
5.1 Global Protease Inhibitors Historic Market Review by Application (2015-2020)
5.1.1 Global Protease Inhibitors Sales Market Share by Application (2015-2020)
5.1.2 Global Protease Inhibitors Revenue Market Share by Application (2015-2020)
5.1.3 Global Protease Inhibitors Price by Application (2015-2020)
5.2 Global Protease Inhibitors Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Protease Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Protease Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Protease Inhibitors Price Forecast by Application (2021-2026)
6 United States Protease Inhibitors Market Facts & Figures
6.1 United States Protease Inhibitors Sales Market Share by Company (2015-2020)
6.2 United States Protease Inhibitors Sales Market Share by Type (2015-2020)
6.3 United States Protease Inhibitors Sales Market Share by Application (2015-2020)
7 Europe Protease Inhibitors Market Facts & Figures
7.1 Europe Protease Inhibitors Sales Market Share by Company (2015-2020)
7.2 Europe Protease Inhibitors Sales Market Share by Type (2015-2020)
7.3 Europe Protease Inhibitors Sales Market Share by Application (2015-2020)
8 China Protease Inhibitors Market Facts & Figures
8.1 China Protease Inhibitors Sales Market Share by Company (2015-2020)
8.2 China Protease Inhibitors Sales Market Share by Type (2015-2020)
8.3 China Protease Inhibitors Sales Market Share by Application (2015-2020)
9 Japan Protease Inhibitors Market Facts & Figures
9.1 Japan Protease Inhibitors Sales Market Share by Company (3015-3030)
9.2 Japan Protease Inhibitors Sales Market Share by Type (2015-2020)
9.3 Japan Protease Inhibitors Sales Market Share by Application (2015-2020)
10 Southeast Asia Protease Inhibitors Market Facts & Figures
10.1 Southeast Asia Protease Inhibitors Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Protease Inhibitors Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Protease Inhibitors Sales Market Share by Application (2015-2020)
11 India Protease Inhibitors Market Facts & Figures
11.1 India Protease Inhibitors Sales Market Share by Company (2015-2020)
11.2 India Protease Inhibitors Sales Market Share by Type (2015-2020)
11.3 India Protease Inhibitors Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Protease Inhibitors Business
12.1 CSL Ltd. (Australia)
12.1.1 CSL Ltd. (Australia) Corporation Information
12.1.2 CSL Ltd. (Australia) Business Overview
12.1.3 CSL Ltd. (Australia) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Ltd. (Australia) Protease Inhibitors Products Offered
12.1.5 CSL Ltd. (Australia) Recent Development
12.2 Grifols S.A (Spain)
12.2.1 Grifols S.A (Spain) Corporation Information
12.2.2 Grifols S.A (Spain) Business Overview
12.2.3 Grifols S.A (Spain) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Grifols S.A (Spain) Protease Inhibitors Products Offered
12.2.5 Grifols S.A (Spain) Recent Development
12.3 Baxalta Incorporated (U.S.)
12.3.1 Baxalta Incorporated (U.S.) Corporation Information
12.3.2 Baxalta Incorporated (U.S.) Business Overview
12.3.3 Baxalta Incorporated (U.S.) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Baxalta Incorporated (U.S.) Protease Inhibitors Products Offered
12.3.5 Baxalta Incorporated (U.S.) Recent Development
12.4 Octapharma AG (Switzerland)
12.4.1 Octapharma AG (Switzerland) Corporation Information
12.4.2 Octapharma AG (Switzerland) Business Overview
12.4.3 Octapharma AG (Switzerland) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Octapharma AG (Switzerland) Protease Inhibitors Products Offered
12.4.5 Octapharma AG (Switzerland) Recent Development
12.5 Kedrion S.p.A (Italy)
12.5.1 Kedrion S.p.A (Italy) Corporation Information
12.5.2 Kedrion S.p.A (Italy) Business Overview
12.5.3 Kedrion S.p.A (Italy) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Kedrion S.p.A (Italy) Protease Inhibitors Products Offered
12.5.5 Kedrion S.p.A (Italy) Recent Development
12.6 China Biologic Products, Inc. (China)
12.6.1 China Biologic Products, Inc. (China) Corporation Information
12.6.2 China Biologic Products, Inc. (China) Business Overview
12.6.3 China Biologic Products, Inc. (China) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.6.4 China Biologic Products, Inc. (China) Protease Inhibitors Products Offered
12.6.5 China Biologic Products, Inc. (China) Recent Development
12.7 Biotest AG (Germany)
12.7.1 Biotest AG (Germany) Corporation Information
12.7.2 Biotest AG (Germany) Business Overview
12.7.3 Biotest AG (Germany) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Biotest AG (Germany) Protease Inhibitors Products Offered
12.7.5 Biotest AG (Germany) Recent Development
12.8 LFB S.A (France)
12.8.1 LFB S.A (France) Corporation Information
12.8.2 LFB S.A (France) Business Overview
12.8.3 LFB S.A (France) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.8.4 LFB S.A (France) Protease Inhibitors Products Offered
12.8.5 LFB S.A (France) Recent Development
12.9 Bio Product Laboratory Ltd. (U.K.)
12.9.1 Bio Product Laboratory Ltd. (U.K.) Corporation Information
12.9.2 Bio Product Laboratory Ltd. (U.K.) Business Overview
12.9.3 Bio Product Laboratory Ltd. (U.K.) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bio Product Laboratory Ltd. (U.K.) Protease Inhibitors Products Offered
12.9.5 Bio Product Laboratory Ltd. (U.K.) Recent Development
12.10 Sanquin (Netherlands)
12.10.1 Sanquin (Netherlands) Corporation Information
12.10.2 Sanquin (Netherlands) Business Overview
12.10.3 Sanquin (Netherlands) Protease Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Sanquin (Netherlands) Protease Inhibitors Products Offered
12.10.5 Sanquin (Netherlands) Recent Development
13 Protease Inhibitors Manufacturing Cost Analysis
13.1 Protease Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Protease Inhibitors
13.4 Protease Inhibitors Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Protease Inhibitors Distributors List
14.3 Protease Inhibitors Customers
15 Market Dynamics
15.1 Protease Inhibitors Market Trends
15.2 Protease Inhibitors Opportunities and Drivers
15.3 Protease Inhibitors Market Challenges
15.4 Protease Inhibitors Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Protease Inhibitors Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Protease Inhibitors Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Protease Inhibitors Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Protease Inhibitors Sales (K MT) by Region (2015-2020)
Table 5. Global Protease Inhibitors Sales Market Share by Region (2015-2020)
Table 6. Global Protease Inhibitors Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Protease Inhibitors Revenue Share by Region (2015-2020)
Table 8. Global Protease Inhibitors Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Protease Inhibitors Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Protease Inhibitors Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Protease Inhibitors Revenue Share Forecast by Region (2021-2026)
Table 12. Global Protease Inhibitors (K MT) of Key Companies (2015-2020)
Table 13. Global Protease Inhibitors Sales Share by Company (2015-2020)
Table 14. Global Protease Inhibitors Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Protease Inhibitors Revenue Share by Company (2015-2020)
Table 16. Global Protease Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Protease Inhibitors as of 2019)
Table 17. Global Protease Inhibitors Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Protease Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers Protease Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Protease Inhibitors Players
Table 22. Global Protease Inhibitors Sales (K MT) by Type (2015-2020)
Table 23. Global Protease Inhibitors Sales Share by Type (2015-2020)
Table 24. Global Protease Inhibitors Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Protease Inhibitors Price (K MT) by Type (2015-2020)
Table 26. Global Protease Inhibitors Sales Share by Type (2021-2026)
Table 27. Global Protease Inhibitors Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Protease Inhibitors Revenue Share by Type (2021-2026)
Table 29. Global Protease Inhibitors Price (K MT) by Type (2021-2026)
Table 30. Global Protease Inhibitors Sales (K MT) by Application (2015-2020)
Table 31. Global Protease Inhibitors Sales Share by Application (2015-2020)
Table 32. Global Protease Inhibitors Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Protease Inhibitors Price (K MT) by Application (2015-2020)
Table 34. Global Protease Inhibitors Sales (K MT) by Application (2021-2026)
Table 35. Global Protease Inhibitors Sales Share by Application (2021-2026)
Table 36. Global Protease Inhibitors Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Protease Inhibitors Revenue Share by Application (2021-2026)
Table 38. Global Protease Inhibitors Price (K MT) by Application (2021-2026)
Table 39. United States Protease Inhibitors Sales (K MT) by Company (2015-2020)
Table 40. United States Protease Inhibitors Sales Market Share by Company (2015-2020)
Table 41. United States Protease Inhibitors Sales (K MT) by Type (2015-2020)
Table 42. United States Protease Inhibitors Sales Market Share by Type (2015-2020)
Table 43. United States Protease Inhibitors Sales (K MT) by Application (2015-2020)
Table 44. United States Protease Inhibitors Sales Market Share by Application (2015-2020)
Table 45. Europe Protease Inhibitors Sales (K MT) by Company (2015-2020)
Table 46. Europe Protease Inhibitors Sales Market Share by Company (2015-2020)
Table 47. Europe Protease Inhibitors Sales (K MT) by Type (2015-2020)
Table 48. Europe Protease Inhibitors Sales Market Share by Type (2015-2020)
Table 49. Europe Protease Inhibitors Sales (K MT) by Application (2015-2020)
Table 50. Europe Protease Inhibitors Sales Market Share by Type (2015-2020)
Table 51. China Protease Inhibitors Sales (K MT) by Company (2015-2020)
Table 52. China Protease Inhibitors Sales Market Share by Company (2015-2020)
Table 53. China Protease Inhibitors Sales (K MT) by Type (2015-2020)
Table 54. China Protease Inhibitors Sales Market Share by Type (2015-2020)
Table 55. China Protease Inhibitors Sales (K MT) by Application (2015-2020)
Table 56. China Protease Inhibitors Sales Market Share by Application (2015-2020)
Table 57. Japan Protease Inhibitors Sales (K MT) by Company (2015-2020)
Table 58. Japan Protease Inhibitors Sales Market Share by Company (2015-2020)
Table 59. Japan Protease Inhibitors Sales (K MT) by Type (2015-2020)
Table 60. Japan Protease Inhibitors Sales Market Share by Type (2015-2020)
Table 61. Japan Protease Inhibitors Sales (K MT) by Application (2015-2020)
Table 62. Japan Protease Inhibitors Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Protease Inhibitors Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Protease Inhibitors Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Protease Inhibitors Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Protease Inhibitors Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Protease Inhibitors Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Protease Inhibitors Sales Market Share by Application (2015-2020)
Table 69. India Protease Inhibitors Sales (K MT) by Company (2015-2020)
Table 70. India Protease Inhibitors Sales Market Share by Company (2015-2020)
Table 71. India Protease Inhibitors Sales (K MT) by Type (2015-2020)
Table 72. India Protease Inhibitors Sales Market Share by Type (2015-2020)
Table 73. India Protease Inhibitors Sales (K MT) by Application (2015-2020)
Table 74. India Protease Inhibitors Sales Market Share by Application (2015-2020)
Table 75. CSL Ltd. (Australia) Corporation Information
Table 76. CSL Ltd. (Australia) Description and Business Overview
Table 77. CSL Ltd. (Australia) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. CSL Ltd. (Australia) Protease Inhibitors Product
Table 79. CSL Ltd. (Australia) Recent Development
Table 80. Grifols S.A (Spain) Corporation Information
Table 81. Grifols S.A (Spain) Description and Business Overview
Table 82. Grifols S.A (Spain) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Grifols S.A (Spain) Protease Inhibitors Product
Table 84. Grifols S.A (Spain) Recent Development
Table 85. Baxalta Incorporated (U.S.) Corporation Information
Table 86. Baxalta Incorporated (U.S.) Description and Business Overview
Table 87. Baxalta Incorporated (U.S.) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Baxalta Incorporated (U.S.) Protease Inhibitors Product
Table 89. Baxalta Incorporated (U.S.) Recent Development
Table 90. Octapharma AG (Switzerland) Corporation Information
Table 91. Octapharma AG (Switzerland) Description and Business Overview
Table 92. Octapharma AG (Switzerland) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Octapharma AG (Switzerland) Protease Inhibitors Product
Table 94. Octapharma AG (Switzerland) Recent Development
Table 95. Kedrion S.p.A (Italy) Corporation Information
Table 96. Kedrion S.p.A (Italy) Description and Business Overview
Table 97. Kedrion S.p.A (Italy) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Kedrion S.p.A (Italy) Protease Inhibitors Product
Table 99. Kedrion S.p.A (Italy) Recent Development
Table 100. China Biologic Products, Inc. (China) Corporation Information
Table 101. China Biologic Products, Inc. (China) Description and Business Overview
Table 102. China Biologic Products, Inc. (China) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. China Biologic Products, Inc. (China) Protease Inhibitors Product
Table 104. China Biologic Products, Inc. (China) Recent Development
Table 105. Biotest AG (Germany) Corporation Information
Table 106. Biotest AG (Germany) Description and Business Overview
Table 107. Biotest AG (Germany) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Biotest AG (Germany) Protease Inhibitors Product
Table 109. Biotest AG (Germany) Recent Development
Table 110. LFB S.A (France) Corporation Information
Table 111. LFB S.A (France) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. LFB S.A (France) Description and Business Overview
Table 113. LFB S.A (France) Protease Inhibitors Product
Table 114. LFB S.A (France) Recent Development
Table 115. Bio Product Laboratory Ltd. (U.K.) Corporation Information
Table 116. Bio Product Laboratory Ltd. (U.K.) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Bio Product Laboratory Ltd. (U.K.) Description and Business Overview
Table 118. Bio Product Laboratory Ltd. (U.K.) Protease Inhibitors Product
Table 119. Bio Product Laboratory Ltd. (U.K.) Recent Development
Table 120. Sanquin (Netherlands) Corporation Information
Table 121. Sanquin (Netherlands) Description and Business Overview
Table 122. Sanquin (Netherlands) Protease Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Sanquin (Netherlands) Protease Inhibitors Product
Table 124. Sanquin (Netherlands) Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Protease Inhibitors Distributors List
Table 128. Protease Inhibitors Customers List
Table 129. Protease Inhibitors Market Key Trends
Table 130. Protease Inhibitors Key Opportunities and Drivers
Table 131. Protease Inhibitors Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Protease Inhibitors Product Picture
Figure 2. Global Protease Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Protease Inhibitors Market Share by Application in 2020 & 2026
Figure 6. Biotechnology Examples
Figure 7. Medicine Examples
Figure 8. Microbiology Examples
Figure 9. Agriculture Examples
Figure 10. Pharmaceuticals Examples
Figure 11. Food additives Examples
Figure 12. Cosmetics Examples
Figure 13. Global Protease Inhibitors Sales (K MT) Growth Rate (2015-2026)
Figure 14. Global Protease Inhibitors Revenue (US$ Million) Growth Rate (2015-2026)
Figure 15. Global Protease Inhibitors Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 16. Global Protease Inhibitors Revenue Market Share by Region: 2015 VS 2020
Figure 17. Global Protease Inhibitors Revenue Market Share by Region: 2021 VS 2026
Figure 18. United States Protease Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. United States Protease Inhibitors Sales (K MT) Growth Rate (2015-2026)
Figure 20. Europe Protease Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Europe Protease Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 22. China Protease Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. China Protease Inhibitors Sales (Million USD) and Growth Rate (2015-2026)
Figure 24. Japan Protease Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Japan Protease Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Protease Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia Protease Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 28. India Protease Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. India Protease Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 30. Global 5 Largest Protease Inhibitors Players Market Share by Revenue in Protease Inhibitors 2015 & 2019
Figure 31. Protease Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 32. Global Protease Inhibitors Revenue Share by Type (2015-2020)
Figure 33. Global Protease Inhibitors Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Global Protease Inhibitors Revenue Share by Application (2015-2020)
Figure 35. Global Protease Inhibitors Revenue Growth Rate by Application in 2015 & 2019
Figure 36. United States Protease Inhibitors Sales Market Share by Type in 2019
Figure 37. United States Protease Inhibitors Sales Market Share by Type in 2019
Figure 38. Europe Protease Inhibitors Sales Market Share by Company in 2019
Figure 39. Europe Protease Inhibitors Sales Market Share by Type in 2019
Figure 40. Europe Protease Inhibitors Sales Market Share by Application in 2019
Figure 41. China Protease Inhibitors Sales Market Share by Company in 2019
Figure 42. China Protease Inhibitors Sales Market Share by Type in 2019
Figure 43. China Protease Inhibitors Sales Market Share by Application in 2019
Figure 44. Japan Protease Inhibitors Sales Market Share by Company in 2019
Figure 45. Japan Protease Inhibitors Sales Market Share by Type in 2019
Figure 46. Japan Protease Inhibitors Sales Market Share by Application in 2019
Figure 47. Southeast Asia Protease Inhibitors Sales Market Share by Company in 2019
Figure 48. Southeast Asia Protease Inhibitors Sales Market Share by Type in 2019
Figure 49. Southeast Asia Protease Inhibitors Sales Market Share by Application in 2019
Figure 50. India Protease Inhibitors Sales Market Share by Company in 2019
Figure 51. India Protease Inhibitors Sales Market Share by Type in 2019
Figure 52. India Protease Inhibitors Sales Market Share by Application in 2019
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Protease Inhibitors
Figure 55. Manufacturing Process Analysis of Protease Inhibitors
Figure 56. Protease Inhibitors Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
プロテアーゼの世界市場レポート2020 A protease (also called a peptidase or proteinase) is an enzyme that catalyzes (increases the rate of) proteolysis, the breakdown of proteins into smaller polypeptides or single amino acids. They do this by cleaving the peptide bonds within proteins by hydrolysis, a reaction where water breaks bonds…- レニン阻害剤の世界市場レポート2020 Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the …
- PD-1・PD-L1阻害剤の世界市場レポート2020 PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer. Nort…
- プロトンポンプ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Proton Pump Inhibitors Market The global Proton Pump Inhibitors market size is projected to reach US$ 2750.5 million by 2026, from US$ 2404.3 million in 2020, at a CAGR of 2.3% during 2021-2026. Global Proton Pump Inhibitors Scope and Market Size The global Proto…
- ヒストンデアセチラーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Histone Deacetylase Inhibitors Market The global Histone Deacetylase Inhibitors market size is projected to reach US$ 2043.7 million by 2026, from US$ 1028 million in 2020, at a CAGR of 12.1% during 2021-2026. Global Histone Deacetylase Inhibitors Scope and Marke…